The n-Lorem Foundation and the EspeRare Foundation announced today a strategic collaboration to expand access in Europe to ...

Codexis expands reach of the ECO Synthesis Manufacturing Platform through a signed evaluation agreement with Axolabs for oligonucleotide therapeutics: Redwood City, California Mon ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.

TherML™ integrates CombinAbleAI’s advanced, next generation biologics expertise with insitro’s existing small molecule and oligonucleotide capabilities, unifying therapeutic design across all major ...

Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and ...

Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and ...

RYTELO® (imetelstat) net product revenue expected in the range of $220 to $240 million2026 total operating expenses expected in the range of ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Health Enterprise Partners ("HEP"), a leading healthcare-focused private equity firm, today announced that Roland Lyon has ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Community Autism Services is proud to announce the grand opening of a new autism learning center in Haverhill, MA, dedicated to providing comprehensive, high-quality care for children with Autism ...